Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13274494 | 1.00 | OPRM1 (0.39) | OPRM1SPHK1LMNADNM1HRH3 | |
| SCHEMBL15740503 | 1.00 | OPRM1 (0.39) | OPRM1SPHK1LMNADNM1HRH3 | |
| SCHEMBL28225528 | 1.00 | OPRM1 (0.39) | OPRM1SPHK1LMNADNM1HRH3 | |
| SCHEMBL15740496 | 1.00 | OPRM1 (0.39) | OPRM1SPHK1LMNADNM1HRH3 | |
| SCHEMBL13274434 | 1.00 | OPRM1 (0.39) | OPRM1SPHK1LMNADNM1HRH3 | |
| SCHEMBL4671901 | 1.00 | OPRM1 (0.39) | OPRM1SPHK1LMNADNM1HRH3 | |
| SCHEMBL24998924 | 0.98 | HRH3 (0.38) | OPRM1SPHK1LMNAHRH3L3MBTL1 | |
| SCHEMBL15740500 | 0.98 | HRH3 (0.38) | OPRM1SPHK1LMNAHRH3L3MBTL1 | |
| Hydrochloric Acid SCHEMBL1802513 | 0.98 | OPRM1 (0.38) | OPRM1SPHK1LMNADNM1HRH3 | |
| SCHEMBL4274121 | 0.98 | HRH3 (0.38) | OPRM1SPHK1LMNAHRH3L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106935907-A | Lithium metal battery | 三星电子株式会社 | 2017-07-07 | — | — | CN | claimed |
| EP-2809611-A1 | USE OF AN IONIC LIQUID FOR STORING HYDROGEN | VTU Holding GmbH (AT) | 2014-12-10 | — | — | EP | claimed |
| WO-2013113452-A1 | USE OF AN IONIC LIQUID FOR STORING HYDROGEN | VTU HOLDING GMBH (AT) | 2013-08-08 | — | — | WO | claimed |
| EP-4648133-A1 | FLUORINATED SALT AS COMPONENT OF ELECTROLYTES FOR IMPROVING PERFORMANCE OF CELLS AND BATTERIES | Fundación Centro de Investigación Cooperativa de Energías Alternativas, CIC Energigune Fundazioa (ES) | 2025-11-12 | — | — | EP | disclosed |
| EP-4377380-A1 | ANTISTATIC TRANSPARENT POLYMER COMPOSITION | ARKEMA FRANCE (FR) | 2024-06-05 | — | — | EP | disclosed |
| WO-2023007092-A1 | ANTISTATIC TRANSPARENT POLYMER COMPOSITION | ARKEMA FRANCE (FR) | 2023-02-02 | — | — | WO | disclosed |
| US-20210380588-A1 | Novel Compounds and Uses Thereof | OXFORD FINANCE LLC | 2021-12-09 | — | — | US | disclosed |
| WO-2020033015-A2 | TRANSIENT POLYMER FORMULATIONS, ARTICLES THEREOF, AND METHODS OF MAKING AND USING SAME | GEORGIA TECH RESEARCH CORPORATION (US) | 2020-02-13 | — | — | WO | disclosed |
| CN-104600352-B | Sodium rechargeable battery with the graphite felt for forming air vent channel | SK INNOVATION CO.,LTD. (KR) | 2019-11-01 | — | — | CN | disclosed |
| CN-107074890-B | Alkenyl (perfluoroalkyl) phosphinic acids | 默克专利股份公司 | 2019-09-24 | — | — | CN | disclosed |
| CN-109628004-A | Film, surface protective film and optical component with finishing coat | 日东电工株式会社 | 2019-04-16 | — | — | CN | disclosed |
| US-7863040-B2 | Ready-to-use whole blood collection vessel | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2011-01-04 | — | — | US | disclosed |
| WO-2010086574-A2 | METHOD FOR SYNTHESISING A BLOCK COPOLYMER ALLOY HAVING IMPROVED ANTISTATIC PROPERTIES | ARKEMA FRANCE (FR) | 2010-08-05 | — | — | WO | disclosed |
| US-7605271-B2 | Superhigh purity ionic liquid | DAI-ICHI KOGYO SEIYAKU CO., LTD (JP) | 2009-10-20 | — | — | US | disclosed |
| US-20090242414-A1 | ELECTRONCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2009-10-01 | — | — | US | disclosed |
| US-20090246866-A1 | READY-TO-USE WHOLE BLOOD COLLECTION VESSEL | ROCHE DIAGNOSTICS GMBH (DE) | 2009-10-01 | — | — | US | disclosed |
| EP-2030013-A1 | READY-TO-USE WHOLE BLOOD COLLECTION VESSEL | Roche Diagnostics GmbH (DE) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007140963-A1 | READY-TO-USE WHOLE BLOOD COLLECTION VESSEL | ROCHE DIAGNOSTICS GMBH (DE) | 2007-12-13 | — | — | WO | disclosed |
| US-20060223995-A1 | Superhigh purity ionic liquid | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1707265-A1 | Superhigh purity ionic liquid | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2006-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380588-A1 | Novel Compounds and Uses Thereof | RB1, VEGFA, UACA | OPRM1 4406/4885SPHK1 1042/4885LMNA 2524/4885 |
| US-20060223995-A1 | Superhigh purity ionic liquid | SLC7A5, SLC7A1, SLC43A1 | OPRM1 3202/4885SPHK1 1630/4885LMNA 2206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.